Prepayments (CK93) - Nykredit Realkredit A/S
To the Nasdaq Copenhagen
Prepayments (CK93)
Pursuant to s 24 of the Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes prepayment data (CK93) as at 17 May 2023 in the attached file.
Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/financial-reporting/prepayments/.
For further information about data format and contents, please refer to the Nasdaq website.
Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.
Yours sincerely
Nykredit Realkredit A/S
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs7.5.2024 13:00:00 CEST | Press release
Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to support ongoing mid- to late-stage clinical development programs for Company’s lead I&I product candidate, obexelimab WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies, today announced the closing of an upsized $200 million Series C preferred stock financing. The financing round was led by SR One along with NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences and Longitude Capital. Additional new investors, the Federated Hermes Kaufmann Funds, and Arrowmark Partners, along with existing investors, Fairmount, Wellington Management, Rock Springs Capital, Pivotal bioVenture Part
JLT Mobile Computers AB (publ) släpper delårsrapport för perioden januari–mars 20247.5.2024 13:00:00 CEST | Pressemelding
Växjö, Sverige, 7:e maj 2024 * * * JLT Mobile Computers, ledande leverantör av stryktåliga datorer för krävande miljöer, släpper idag delårsrapport för perioden januari–mars 2024. Periodens resultat i korthet Orderingång 33,7 MSEK (34,0)Omsättning 37,7 MSEK (49,9)Rörelseresultat 0,8 MSEK (2,6)Resultat efter skatt 0,5 MSEK (2,2) Kortsummering Orderingången för första kvartalet slutade på 34 MSEK, samma nivå som första kvartalet föregående år Fortsatt svag efterfrågan på JLT:s målmarknader, speciellt inom transport- och logistiksegmenten, påverkade omsättningen negativt under första kvartaletDen lägre efterfrågan i transport- och logistiksegmenten kompenserades till viss del av en hög aktivitet hos våra OEM-kunder inom jordbruk och entreprenad, samt våra hamnkunderFör att anpassa verksamheten till rådande konjunkturläge har vi infört kostnadsbesparande åtgärder vilka började ge resultat under kvartalet. JLT säkrade en betydande order värd nästan 6 miljoner kronor för ruggade Android-dato
JLT Mobile Computers AB (publ) publishes interim report for January–March 20247.5.2024 13:00:00 CEST | Press release
Växjö, Sweden, 7 May 2024 * * * JLT Mobile Computers, a leading supplier of rugged computers for demanding environments, publishes its interim report for the period January–March 2024 today. Summary of key figures Order intake 33.7 MSEK (34.0)Net sales 37.7 MSEK (49.9)Operating profit 0.8 MSEK (2.6)Profit after taxes 0.5 MSEK (2.2) In short The order intake for the first quarter ended at 34 million SEK, the same level as the first quarter of the previous year.Continued weak demand in target markets, especially transportation and logistics segments, impacted the revenue negatively during the first quarter. Lower demand in transportation and logistics was partially offset by strong activity from OEM customers in agriculture, construction, and port customers.To adapt the operations to the prevailing economic situation, cost-saving measures have been implemented and began yielding results during the quarter.JLT secured a significant order worth nearly 6 million SEK for the rugged Android c
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems7.5.2024 12:45:00 CEST | Press release
ATLANTA and LONDON, May 07, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, released findings from Online Buying Grows, But Too Many Consumers Still Experiencing Delivery Woes, its third annual consumer sentiment study of ecommerce home delivery. The study shows that 39% of respondents made more online purchases in the period surveyed this year compared to last year, and that 57% made purchases in at least one new product category this year. While the study revealed that consumers in every demographic are increasing the volume and frequency of their online purchases, 67% of those surveyed encountered delivery problems. What’s more, delivery issues were also cited in the study as a potential barrier to future online buying. When consumers were asked what would put them off making more online purchases in the future, 21% indicated they have had negative delivery experiences, 20% said deliv
Resolutions of the Annual General Meeting of Shareholders of AS Tallink Grupp7.5.2024 12:45:00 CEST | Press release
AS Tallink Grupp (registration code 10238429, location and address at Sadama 5, 10111 Tallinn) held its Annual General Meeting of Shareholders on 7 May 2024 at 11 AM at the conference centre of Tallink SPA & Conference Hotel, at the address Sadama 11a, Tallinn. 86 shareholders were registered as attending at the Annual General Meeting of Shareholders, who owned 571,294,959 votes/shares (the amount of represented share capital 268,508,630.73 EUR), forming 76.83% of AS Tallink Grupp share capital. Resolutions adopted at the meeting: 1. To approve the annual report of the financial year 2023 of AS Tallink Grupp presented by the Management Board. In favour of the resolution voted 98.99% of the votes represented at the meeting (565,513,785 votes). 2. To approve the following profit allocation proposal of AS Tallink Grupp prepared by the Management Board: 1) To approve the net profit of the financial year of 2023 in the sum of 78 872 000 euros; 2) Not to make any allocations to the mandatory